Elder Pharmaceuticals Ltd Annually Results

Gross Sales

1,006.13

1,638.53

1,454.28

1,332.32

964.28

Excise Duty

0

0

0

0

0

Net Sales

1,006.13

1,638.53

1,454.28

1,332.32

964.28

Other Operating Income

2.76

3.17

2.34

2.45

1

Other Income

396.92

32.7

30.59

28.04

8.65

Total Income

1,405.83

1,674.4

1,487.21

1,362.81

973.95

Total Expenditure

1,088.09

1,371.18

1,241.03

1,135.76

799.29

PBIDT

317.73

303.2

246.19

227.05

174.64

Interest

275.63

154.83

107.01

101.56

65.51

PBDT

42.11

148.38

139.16

125.48

109.13

Depreciation

36.13

44.08

35.91

33.97

28.72

Minority Interest Before NP

0

0

0

0

0

Tax

3.25

21.92

21.94

19.27

16.86

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

2.73

82.38

81.3

72.23

63.54

Minority Interest After NP

0

0

0

0

-0.67

Net Profit after Minority Interest

2.73

82.38

81.3

72.23

64.22

Extra-ordinary Items

368.01

-2.24

0

1.17

-3.56

Adjusted Profit After Extra-ordinary item

-365.28

84.62

81.3

71.05

67.79

EPS (Unit Curr.)

1.33

40.11

39.59

35.18

32.54

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

20.54

20.54

20.54

20.54

20.54

Public Shareholding (Number)

1,53,49,156

1,34,71,572

1,23,23,853

1,24,04,803

1,26,37,837

Public Shareholding (%)

74.73

65.59

60

60.4

61.54

Pledged/Encumbered - No. of Shares

46,66,131

70,24,370

65,81,802

47,73,802

35,79,150

Pledged/Encumbered - % in Total Promoters Holding

89.94

99.41

80.13

58.7

45.31

Pledged/Encumbered - % in Total Equity

22.71

34.2

32.04

23.23

17.43

Non Encumbered - No. of Shares

5,21,649

40,994

16,31,281

33,58,331

43,19,949

Non Encumbered - % in Total Promoters Holding

10.06

0.57

19.86

41.29

54.68

Non Encumbered - % in Total Equity

2.53

0.2

7.94

16.35

21.04

PBIDTM(%)

31.58

18.5

16.92

17.04

18.11

PBDTM(%)

4.18

9.05

9.56

9.41

11.31

PATM(%)

0.27

5.02

5.59

5.42

6.59